Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Brain Imaging01:14

Brain Imaging

308
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
308
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

736
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
736
The Placebo Effect01:54

The Placebo Effect

6.3K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generalizable structure-function covariation predictive of antidepressant response revealed by target-oriented multimodal fusion.

Nature. Mental health·2026
Same author

The effect of cumulative trauma load on suicide risk and thoughts in trauma-exposed youth over two years.

Journal of affective disorders·2026
Same author

Anhedonia in patients with major depressive disorder (MDD): State-of-the-art consensus review.

Psychiatry research·2026
Same author

Progress on Pharmacogenetic Tests for Antidepressant Drug Selection Requires Properly Designed Studies.

Journal of clinical psychopharmacology·2026
Same author

Childhood Maltreatment in the Context of Familial Bipolar I Disorder Risk Predicts Major Depressive Disorder in Adolescents.

JAACAP open·2026
Same author

Relationships Among Dementia, Parental Death, and Other Adverse Childhood Experiences: Systematic Review and Meta-Analysis.

The Journal of neuropsychiatry and clinical neurosciences·2026

Related Experiment Video

Updated: Sep 9, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.1K

Early Brain Functional Connectivity Changes Induced by Antidepressants and Placebo.

Xiaoyu Tong1, Gregory A Fonzo2, Nancy B Carlisle3

  • 1Department of Bioengineering, Lehigh University, Bethlehem, PA, USA.

Biorxiv : the Preprint Server for Biology
|September 5, 2025
PubMed
Summary

Early brain connectivity changes in major depressive disorder (MDD) reveal common and distinct treatment mechanisms. Functional connectivity in a visual-precuneus-thalamus network increased, with specific brain areas showing drug or placebo effects.

More Related Videos

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.7K
Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity
10:43

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity

Published on: July 1, 2014

15.3K

Related Experiment Videos

Last Updated: Sep 9, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.1K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.7K
Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity
10:43

Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity

Published on: July 1, 2014

15.3K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Imaging

Background:

  • Major depressive disorder (MDD) is a prevalent mental health condition with significant unmet needs for precise treatments.
  • Brain imaging studies have identified neural correlates of MDD diagnosis and treatment response, but early circuit-level changes remain elusive.

Purpose of the Study:

  • To investigate early changes in functional brain connectivity within the first two weeks of antidepressant or placebo treatment in patients with MDD.
  • To differentiate common network alterations from treatment-specific effects and placebo responses.

Main Methods:

  • Analysis of functional connectivity in two independent cohorts of MDD patients undergoing treatment.
  • Utilized brain imaging techniques to examine neural network engagement during early treatment phases.
  • Employed a placebo response prediction model to analyze treatment outcomes.

Main Results:

  • A consistent increase in functional connectivity within the visual-precuneus-thalamus network was observed across all patients, irrespective of treatment.
  • Placebo response was associated with alterations in attention and striatal systems.
  • Drug-specific effects, localized to the amygdala, mid-cingulate, orbitofrontal cortex, and cerebellum, emerged in a subset of medicated patients.
  • A placebo response prediction model successfully predicted outcomes for patients without drug-specific changes.

Conclusions:

  • Early functional connectivity changes provide insights into both shared and distinct mechanisms underlying MDD treatment response.
  • Identified specific neural circuits modulated by antidepressants versus placebo.
  • Findings suggest potential for personalized interventions based on early neurobiological markers in MDD.